TFS Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

TFS Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,294	Closed	-$432K	–	809
2017 Q1	$432K	Buy	+15,294	New	+$406K	0.14%	267
2016 Q4	–	Sell	-32,914	Closed	-$781K	–	931
2016 Q3	$781K	Buy	+32,914	New	+$721K	0.19%	173
2014 Q2	–	Sell	-17,452	Closed	-$555K	–	1415
2014 Q1	$555K	Buy	+17,452	New	+$576K	0.04%	691
2013 Q3	–	Sell	-122,919	Closed	-$2.61M	–	1670
2013 Q2	$2.61M	Buy	+122,919	New	+$2.39M	0.11%	269

Other funds holding CSII

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

TFS Capital's CSII Position: Q2 2017 in Review

TFS Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2017, closing a stake of 15,294 shares — an estimated $432K sold.

TFS Capital first reported a position in CSII in Q2 2013 and held it in 4 quarters. The position peaked at $2.61M in Q2 2013. 157 funds tracked by Wall St. Rank hold CSII as of Q2 2017.

TFS Capital reported no remaining Cardiovascular Systems, Inc. position as of Q2 2017 after selling out during the quarter.
TFS Capital sold 15,294 Cardiovascular Systems, Inc. shares in Q2 2017, an estimated $432K.
TFS Capital first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 4 quarters.
TFS Capital's Cardiovascular Systems, Inc. position peaked at $2.61M in Q2 2013.
157 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.